Overview
Adipotide is a synthetic peptide construct designed to target prohibitin, a protein associated with the vasculature that supplies adipose tissue. Its targeting design gives it a research-friendly profile as a probe of the blood supply serving fat depots rather than of fat cells directly.
In preclinical models Adipotide has been studied for its relationship to prohibitin-associated adipose-tissue vasculature and the mechanisms by which the microvascular support of fat depots can be experimentally modulated. Researchers examining metabolic and adipose biology have used it as a research material to investigate these vascular-targeting pathways in cell-based and animal systems.
What makes Adipotide a notable entry for a metabolic research catalog is its focus on the vascular compartment of adipose tissue as a distinct experimental target. Whether these mechanisms translate to female physiology remains an open research question; our evidence review tracks how many of the underlying studies included women.
Summary
Adipotide is a peptidomimetic that targets the blood supply of white fat, causing weight loss in obese animals (including monkeys). It has not advanced to established human trials, earlier work flagged kidney effects, and there is no female-specific data.
Evidence in women
Mechanism
A targeting peptide linked to a pro-apoptotic sequence that homes to prohibitin on fat-tissue blood vessels, triggering their regression.
Free research guide
How to tell real female data from male-extrapolated claims, with the questions to ask about any compound.
Citations (PMID)
Related peptides
Educational information for laboratory and research use only. Not medical advice, a recommendation, or a claim of safety or efficacy; no personal dosing. “Unstudied” means no qualifying study was found, not that a compound is safe or unsafe.